Riverhead Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $400K | Buy |
2,250
+500
| +29% | +$88.9K | 0.01% | 817 |
|
|
2019
Q2 | $456K | Buy |
1,750
+50
| +3% | +$13K | 0.02% | 758 |
|
|
2019
Q1 | $485K | Buy |
1,700
+100
| +6% | +$28.5K | 0.02% | 721 |
|
|
2018
Q4 | $520K | Sell |
1,600
-199
| -11% | -$64.7K | 0.02% | 645 |
|
|
2018
Q3 | $809K | Sell |
1,799
-4,489
| -71% | -$2.02M | 0.03% | 555 |
|
|
2018
Q2 | $2.57M | Buy |
6,288
+779
| +14% | +$319K | 0.1% | 261 |
|
|
2018
Q1 | $1.6M | Buy |
5,509
+430
| +8% | +$125K | 0.07% | 319 |
|
|
2017
Q4 | $952K | Buy |
5,079
+1,520
| +43% | +$285K | 0.04% | 445 |
|
|
2017
Q3 | $600K | Buy |
3,559
+439
| +14% | +$74K | 0.03% | 547 |
|
|
2017
Q2 | $447K | Buy |
3,120
+1,320
| +73% | +$189K | 0.02% | 624 |
|
|
2017
Q1 | $225K | Sell |
1,800
-480
| -21% | -$60K | 0.01% | 744 |
|
|
2016
Q4 | $257K | Buy |
2,280
+690
| +43% | +$77.8K | 0.02% | 663 |
|
|
2016
Q3 | $204K | Sell |
1,590
-59,526
| -97% | -$7.64M | 0.01% | 681 |
|
|
2016
Q2 | $2.4M | Buy |
61,116
+55,416
| +972% | +$2.18M | 0.08% | 282 |
|
|
2016
Q1 | $541K | Sell |
5,700
-1,900
| -25% | -$180K | 0.01% | 846 |
|
|
2015
Q4 | $686K | Buy |
7,600
+5,800
| +322% | +$524K | 0.01% | 742 |
|
|
2015
Q3 | $167K | Buy |
+1,800
| New | +$167K | ﹤0.01% | 770 |
|